ICON Central Laboratories launches Cytometry Services, Clinical News | May 26, 2011. ( http://www.pharmatimes.com/Article/11-05-26/ICON_Central_Laboratories_launches_Cytometry_Services.aspx)
The Central Laboratories arm of ICON, the global provider of outsourced development services based in Ireland, has launched a global Cytometry Services offering through its facilities in New York (US), Dublin (Ireland), Bangalore (India) and Singapore.
The new full-service solution consists of two strands tailored to the particular testing requirements and development phase of a client's compound. Clients can work with ICON during the early stages of product development to create compound-specific assays. The ICON Central Laboratories R&D team will collaborate on developing a unique Flow Cytometry methodology, customized standard operating procedures and other special requirements including reporting, the company said.
ICON Cytometry Services' other offering gives clients the choice of a wide range of fully validated assays and "is often suited to the large scale, high-volume requirements of later phase global trials", the company noted.
Flow Cytometry "has become a preferred testing method for many of our clients, particularly those with autoimmune, oncology and immunodeficiency compounds that require more specialized testing", pointed out Tom O'Leary, president of ICON Central Laboratories.